Compare Baxter International Inc (BAX) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Wendys Co — how do they compare? Baxter International Inc trades at $26.77 (market cap $14.27B), while Wendys Co trades at $7.73 (market cap $1.44B). The key difference: Baxter International Inc is far larger — about 9.9× Wendys Co's market cap, and Wendys Co pays the higher dividend (3.71%). Which is the better fit depends on your goals.
| BAX | WEN | |
|---|---|---|
Market Cap | $14.27B | $1.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $28.35 | $10.68 |
52-Week Low | $15.80 | $6.17 |
Enterprise Value | $21.79B | $5.17B |
Dividend Yield | 0.14% | 3.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baxter International Inc. (BAX) trades at $27.78, up 0.83% today, with a bullish technical outlook supported by moving averages. Recent Q2 2026 earnings beat estimates with EPS of $0.56 versus $0.37 expected, and revenue guidance was raised, signaling operational improvement. However, the company posted a net loss of -$957 million in 2025, with negative profit margins and high P/E of 87.85, reflecting valuation concerns amid turnaround efforts.
The stock shows potential from earnings momentum and cost initiatives, but high debt and inconsistent profitability pose risks. Analyst consensus is mixed with a $25.43 price target below current levels, suggesting cautious optimism. Investors should weigh recent beats against structural challenges in the medtech sector.
Wendy's stock (WEN) trades at $7.30, down 5.07% amid significant operational challenges. The company faces declining U.S. traffic, a 50% dividend cut, and loss of its position as America's second-largest burger chain to Burger King. Despite beating Q2 2026 EPS estimates ($0.18 vs. $0.16 expected), revenue trends remain weak with profit margins contracting from 7.58% in 2025 to 5.72% projected for 2026. Technical indicators show bearish momentum with key support at $7.00.
The outlook remains challenging as new CEO Bob Wright implements a turnaround strategy. While valuation appears reasonable (P/E 11.44, P/S 0.65), execution risks are elevated given competitive pressures and $2.66 billion debt load. Analyst sentiment is mixed with 62.75% hold ratings, reflecting uncertainty about the company's ability to regain market share and improve franchisee economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
